Changes coming to Michigan’s public funding system for addiction and mental health services?

There an article in Bridge magazine that does a great job bringing us up to speed on proposed changes to the funding system. (This is just a portion. Please go read the entire article here.)

For over a year, intense review has taken place across Michigan on a critical matter. How it is resolved will say much about our state.

On one side are powerful private insurers, who think about ways to increase profits. On the other are consumers of mental health service and their families and advocates, who think about survival.

The issue began in February 2016, when Gov. Rick Snyder proposed transferring $2.5 billion of Medicaid mental health money from governmental Community Mental Health Services Programs (CMHSPs) to the state’s 11 private Medicaid HMOs (also known as Medicaid Health Plans, or MHPs). The latter contract with the state to manage “physical” health care of many Medicaid beneficiaries.

The governor’s proposal was put on hold after public outcry. Since then, the state has done three major reviews of the issue. Each time, the governor’s plan was rejected.

First, Lt. Gov. Brian Calley formed a 120-person work group in early 2016. It recommended the publicly funded mental health system remain under CMHSP management.

Next, 45 affinity group sessions were held across the state last fall. Two-thirds of these were for service recipients and families, attended by over 700 people, who stated overwhelmingly they didn’t want MHPs controlling their mental health care. Additionally, the 15 affinity groups for service providers and payers yielded no recommendation supporting the Governor’s proposal.

Finally, the Department of Health and Human Services (DHHS) appointed a 23-person workgroup to develop reports to the Legislature, delivered this January and March. Again, it was recommended that CMHSPs lead publicly funded mental health care and MHPs lead publicly funded care for other medical conditions. It was further recommended that joint CMHSP-MHP programming for shared enrollees be strengthened. These reports had over 70 recommendations, many targeted to improving the state’s mental health system.

You would think that would settle the matter.

However, there are rumblings in Lansing that legislature may not follow the recommendations of these 3 workgroups.

If this concerns you, call your State Senator and State Representative.

Comments Off on Changes coming to Michigan’s public funding system for addiction and mental health services?

Filed under Uncategorized

Vancouver OD deaths keep rising

From the Vancouver Sun:

More than 20 temporary supervised injection sites opened in Vancouver, Victoria and across the province and a mobile medical unit was deployed — although medical staff have since been withdrawn — in the Downtown Eastside, all of them kitted out with life-saving naloxone and trained staff. More than 3,000 overdose events have been safely managed since late December.

Despite these measures, more than 100 people have died due to drug overdose so far this year in Vancouver, a pace that would see 400 people dead by the end of the year. There were 216 overdose deaths in Vancouver last year and 922 in the province, roughly five times the number for an average year.

And, the provincial context from David Juurlink:

 

Comments Off on Vancouver OD deaths keep rising

Filed under Uncategorized

A tweet to ponder

//platform.twitter.com/widgets.js

Comments Off on A tweet to ponder

Filed under Uncategorized

Sentences to ponder

Shared by my friend Chris Budnick. (emphasis his)

“During the 1920s and 1930s a growing number of physicians and public health professionals came to view addiction as a manifestation of psychopathy or some other form of twisted personality, to support mandatory institutionalization of addicts, and to refuse to supply addicts (especially the nonmedical type) with opiates. The average doctor came to think of the average addict as somehow beyond the pale, an unstable and compulsive personality better left to the management of the police or other authorities. This hardening of attitudes resulted at least in part from the fact that physicians were exposed to an increasingly lower-class type of addict; witnessing the transformation first hand, they did not much like what they saw. In previous decades, however, when addicts were drawn primarily from the middle and upper classes and often were addicted through medical practice, attitudes of both doctors and laity were generally more tolerant. Willis P. Butler, a crusty, nonagenarian physician who in 1919 established a morphine maintenance and treatment program in Shreveport, Louisiana, likes to illustrate this point with an anecdote. One day a prominent citizen walked up to him and denounced his addicted patients as ‘hopheads’ who ought to be run into the river. Irritated, Butler took the visitor aside and confided that the man’s own 75-year old mother, an asthma sufferer who had been addicted for more than 20 years, was a regular patient at the clinic. Once he overcame his surprise and shock, the erstwhile critic became one of the program’s staunchest supporters. The moral of this story is one of the central themes of this book: what we think about addiction very much depends on who is addicted.

Dark Paradise: A History of Opiate Addiction in America by David Courtwright (1982)

1 Comment

Filed under Uncategorized

It’s beginning to feel like big tobacco all over again (part 2)

Claire McCaskill ratchets things up a notch:

A leading Democratic senator is investigating the nation’s top opioid manufacturers to determine whether they contributed to overuse of the painkillers at the center of a deadly addiction crisis that has led to nearly 200,000 overdose deaths in the past 15 years.

Sen. Claire McCaskill of Missouri on Tuesday asked the manufacturers of the nation’s five biggest selling prescription opioid products for internal information including marketing plans, sales records and contributions to third-party advocacy groups.

. . .

McCaskill’s letters to Purdue Pharma, Johnson & Johnson’s Janssen Pharmaceuticals, Insys Therapeutics, Mylan and Depomed specifically ask for information about any payments the companies made to 17 third-party advocacy groups — including the Pain Care Forum, a little-known but powerful coalition of drug companies and nonprofit groups highlighted in the Politics of Pain series.

At least 13 of the other advocacy groups mentioned in her letters have belonged to that coalition organized by the chief lobbyist for OxyContin-maker Purdue Pharma, according to the Center for Public Integrity and AP’s review of its membership directories.

The AP/Center for Public Integrity series found that members of the Pain Care Forum met with some of the highest-ranking health officials in the federal government, while quietly working to influence proposed regulations on opioids and promote legislation and reports on the problem of untreated pain.

President Trump also just announced that Chris Christie will run the White House Opioid Commission:

President Trump will soon sign an executive order that creates a commission to tackle the opioid epidemic and has reportedly put New Jersey Gov. Chris Christie in charge of it.

Christie is a strong choice, given that just this February, he signed into law one of the nation’s most comprehensive laws to combat the growing opioid and heroin crisis.

New Jersey’s law reduces the supply of drugs that patients getting their first opioid prescription can obtain from 30 days to five days, which as research has shown plays a huge role in whether a person gets hooked. It also will require doctors to talk to patients about how addictive the drugs are. For addicts whose doctors have recommended treatment, the law also mandates that insurers offer 180 days of coverage without preauthorization.

Comments Off on It’s beginning to feel like big tobacco all over again (part 2)

Filed under Uncategorized

Voice Your Opinion on Funding changes for Michigan’s Addiction and Mental Health Services

historyDo you recall the post about potential changes to Michigan’s public funding for addiction treatment and mental health services?

Well, the final report came in and it looked a lot like the interim report that my earlier post reported on. Basically, no major changes, but try some pilots to increase integration with physical health care.

This seems sensible, given the uncertain future of medicaid expansion.

But, it’s not over yet. I received the following from the Michigan Association of Mental Health Boards.

We need you, within the next two weeks (prior to April 10, when any 298-related change to the FY18 budget will be nearly wrapped up), to contact the House and Senate Appropriations Committee members. We also need you to ask members of your Board of Directors, your staff, and your community partners to make those same contacts.  These contacts are critical to support the solid recommendations contained in the 298 Report, and to counter the efforts by others opposed to the public management of the state’s publicly sponsored behavioral health and intellectual/developmental disability services and supports system.
Legislators are hearing from the private sector on this issue; see the attached Crain’s Detroit Business article (March 9, 2017) where DHHS budget committee chairs raise questions about the lack of MHP pilots in the 298 process.  We must raise our concerns to those suggestions.
Click the link below to log in and send your message:

Comments Off on Voice Your Opinion on Funding changes for Michigan’s Addiction and Mental Health Services

Filed under Uncategorized

It’s beginning to feel like big tobacco all over again

There’s, this:

City officials in Everett – that’s in western Washington state – are taking a bold step in their effort to control the opioid crisis. The city filed a lawsuit against the manufacturer of OxyContin, a leading opioid pain medication, claiming the manufacturer knew the drug was being illegally trafficked to residents and did not act to stop it. The suit accuses the manufacturer, Purdue Pharma, of gross negligence.

And, this:

Attorneys in West Virginia, which has the highest opioid overdose rate in the nation, filed lawsuits in federal court Thursday on behalf of two counties and targeting some of the nation’s largest drug distribution companies. A dozen attorneys general in hard-hit states are considering similar suits against many of the same companies.

“The purpose of these lawsuits is to make the economic cost of willfully violating the law so significant that we force the wholesalers to abide by the law,” said Paul Farrell Jr., who filed the lawsuits in West Virginia and plans to file lawsuits on behalf of five other counties in the state next week.

The suits are among the first of their kind in the country. They accuse the companies of creating a hazard to public health and safety by shipping inordinate quantities of opioids into the state in violation of a West Virginia law. The law was originally designed to permit the demolition of run-down buildings that posed a public nuisance and threatened the safety of a community.

The lawsuits name McKesson Corp., Cardinal Health and AmerisourceBergen — which distribute 85 percent of the nation’s drugs. Also named are Walgreens, CVS and others.

And, this:

The County Legislature voted Thursday to have Schenectady County become the fourth New York county to sue large pharmacy companies over costs incurred by the county in fighting the epidemic of heroin and prescription opioid abuse.

The lawsuit charges that some drug manufacturers promoted long-established opioid drugs for use as long-term painkillers — despite knowing their addictive properties — and that that has lead to overdose deaths and greater social services, law enforcement and jail costs for the county, as people become addicted and commit crimes to get or pay for drugs.

And, this:

The Simmons Hanly Conroy firm has filed several lawsuits on behalf of New York counties against pharmaceutical manufacturers and physicians, alleging the counties have spent millions of dollars fighting an opioid drug epidemic they say was caused by aggressive marketing.

“As a direct and foreseeable consequence of Defendants’ wrongful conduct, Plaintiff has been required to spend millions of dollars each year in its efforts to combat the public nuisance created by Defendants’ deceptive marketing campaign,” the suits state.

The Simmons firm, based in Alton, has built its business on asbestos litigation. It filed its most recent suits on behalf of Erie County in Buffalo on the state’s western border and Broome County in Binghamton in south central last month in those respective state courts.

And, the Teamsters:

Newly focused on an issue that is ravaging its members, the International Brotherhood of Teamsters on Thursday plans to challenge one of the world’s biggest pharmaceutical wholesalers, demanding that AmerisourceBergen Corp. investigate its own sales practices and potential supply chain diversions, and factor compliance into its executives’ pay.

The Chesterbrook-based company, ranked 12th by revenue on the Fortune 500, is holding its annual shareholder meeting in Philadelphia, and the union pension and benefits funds own an undisclosed share. But any shareholder can attend the closed meeting. Representatives said they will question the board and hold an afternoon rally outside.

The response could be characterized as blaming the victim, claiming that the lawsuits are diverting attention from addressing the crisis.

4 Comments

Filed under Uncategorized